Dorsch, M., Pokorney, S., Birmingham, M., House, J. A., Moore, K., James, B., … Hylek, E. (2019). ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS. In Journal of the American College of Cardiology (Vol. 73, pp. 408–408). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)31016-2

Dorsch, Michael, Sean Pokorney, Mary Birmingham, John A. House, Kenneth Moore, Bobbie James, Sue Mashni, et al. “ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS.” In Journal of the American College of Cardiology, 73:408–408. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)31016-2.

Dorsch M, Pokorney S, Birmingham M, House JA, Moore K, James B, et al. ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS. In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 408–408.

Dorsch, Michael, et al. “ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS.” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 408–408. Crossref, doi:10.1016/s0735-1097(19)31016-2.

Dorsch M, Pokorney S, Birmingham M, House JA, Moore K, James B, Mashni S, Thomas K, Anstrom K, Naccarelli G, Berger P, Fermann G, Granger CB, Hylek E. ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS. Journal of the American College of Cardiology. Elsevier BV; 2019. p. 408–408.